International Conference on Ear, Nose and Throat Disorders, July 06-08, 2017, Kuala Lumpur, Malaysia welcomes you in the discipline of Otorhinolaryngology, Head and Neck oncology, Surgical ENT for healthcare practice. Meet Surgery Experts, ENT Experts from Asia Pacific, Middle East, Europe and USA. Submit abstract in this emerging field to seek potential focus in diagnosis of ENT Disorders at Cli
Enabling Gynecologists and Urogynecologists to Offer Advanced Treatments for a Variety of Gynecological and Vaginal Health Conditions and Expand their Practice Offering.
Gene walks once again! Andy Dolan, and Gene Laureano a retired Army Specialist who suffered a Spinal Cord Injury will showcase how the ReWalk exoskeleton enables Gene to walk again. This moving demonstration highlights the achievements of persons with disabilities on the United Nations International Day of Persons with Disabilities.
License agreement reached with UCSD office of innovation and commercialization for patent and intellectual property for linking a drug to a nanocrystal scintillator activated radiosurgically.
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF).
Terason, the leading developer of next generation ultrasound technology now introduces "uSmart 3300", a perfect fusion of cutting-edge technology with grab-and-go portability.
Six pioneering French companies who will be exhibiting at the group pavilion run by Business France in the innovation area at Medica 2016 in Düsseldorf between 14th-17th November 2016. With around 700 new patent applications filed every year and estimated to be worth around £13 billion, the French medical devices and in vitro diagnostics sector is certainly one to watch.
This webinar will benefit any consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance.
Exosome Diagnostics, Inc. has entered into an agreement with Amgen to evaluate the potential to advance drug development with Exosome's proprietary liquid biopsy diagnostics technology and platform.
SMi Group reports (2016.10.04 - London, UK): World Courier, Finnair, MHRA, IATA, Teva, GSK, J&J, Sanofi will meet in London this December at Cold Chain Distribution 2016
Lundbeck to give guidance on strengthening digital strategies by understanding social channels at Social Media in the Pharmaceutical Industry in January.
JPA Health Communications grows its Boston office with a move to Boston's Financial District and the addition of two senior level professionals to the team.
On June 14 of 2016, FDA has strengthened existing warnings about the risk of acute kidney injury associated with the SGLT2 inhibitors, canagliflozin (brand names Invokana, Invokamet) and dapagliflozin (brand names Farxiga, Xigduo XR).